Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statements of Operations

v3.25.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Product revenue, net $ 17,025 $ 14,629 $ 45,173 $ 42,514
Total other revenues 606   606  
Total revenue 17,631 14,629 45,779 42,514
Operating expenses        
Cost of goods sold - (excluding amortization of acquired intangible assets) 5,755 4,471 15,484 16,199
Amortization of acquired intangible assets 1,064 814 3,193 2,443
Research and development 287 842 326 9,639
Selling, general and administrative 12,054 11,396 34,505 30,144
Total operating expenses 19,160 17,523 53,508 58,425
Loss from operations (1,529) (2,894) (7,729) (15,911)
Other expense (income)        
Interest income (154) (188) (441) (566)
Interest expense 937 758 2,765 1,869
Foreign exchange transaction losses 3 51 71 104
Gain on extinguishment of debt   (1,125)   (1,125)
Total other expense (income) 786 (504) 2,395 282
Loss before income taxes (2,315) (2,390) (10,124) (16,193)
Income tax expense     60  
Net loss $ (2,315) $ (2,390) $ (10,184) $ (16,193)
Net loss per common share:        
Basic (In dollars per share) $ (0.09) $ (0.12) $ (0.43) $ (0.8)
Diluted (In dollars per share) $ (0.09) $ (0.12) $ (0.43) $ (0.8)
Weighted average number of common shares:        
Basic (In shares) 24,959,114 20,537,794 23,628,921 20,137,942
Diluted (In shares) 24,959,114 20,537,794 23,628,921 20,137,942